Joakim Bjerketorp

1.1k total citations
29 papers, 842 citations indexed

About

Joakim Bjerketorp is a scholar working on Molecular Biology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Joakim Bjerketorp has authored 29 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Infectious Diseases and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Joakim Bjerketorp's work include Streptococcal Infections and Treatments (7 papers), Microbial Natural Products and Biosynthesis (6 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Joakim Bjerketorp is often cited by papers focused on Streptococcal Infections and Treatments (7 papers), Microbial Natural Products and Biosynthesis (6 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Joakim Bjerketorp collaborates with scholars based in Sweden, Singapore and Germany. Joakim Bjerketorp's co-authors include Janet Jansson, Lars Frykberg, Karin Jacobsson, Klas Hjort, Benjamin P. Willing, Zhigang Wu, Sebastian Håkansson, Martin Nilsson, Shimshon Belkin and Bengt Guss and has published in prestigious journals such as Environmental Pollution, Applied Microbiology and Biotechnology and Molecules.

In The Last Decade

Joakim Bjerketorp

25 papers receiving 824 citations

Peers

Countries citing papers authored by Joakim Bjerketorp

Since Specialization

Citations

This map shows the geographic impact of Joakim Bjerketorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joakim Bjerketorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joakim Bjerketorp more than expected).

Fields of papers citing papers by Joakim Bjerketorp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joakim Bjerketorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joakim Bjerketorp. The network helps show where Joakim Bjerketorp may publish in the future.

Co-authorship network of co-authors of Joakim Bjerketorp

This figure shows the co-authorship network connecting the top 25 collaborators of Joakim Bjerketorp. A scholar is included among the top collaborators of Joakim Bjerketorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joakim Bjerketorp. Joakim Bjerketorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reining in strangles: Absence of disease in horses vaccinated with a DIVA‐compatible recombinant fusion protein vaccine, Strangvac, following natural exposure to Streptococcus equi subspecies equi 2025 ·Equine Veterinary Journal ·(unknown), Francesco Righetti, Anna Aspán, Joakim Bjerketorp, Sara Frosth, Lars Frykberg, Karin Jacobsson, Bengt Guss, Romain Paillot, Jan‐Ingmar Flock, Birgitta Henriques‐Normark, Andrew S. Waller	0
2	Closing the Stable Door on Strangles: Serological Responses of Vaccinated Horses on a Farm Following the Arrival of a New Horse 2025 ·Animals ·(unknown), Francesco Righetti, (unknown), Joakim Bjerketorp, Sara Frosth, Lars Frykberg, Karin Jacobsson, Bengt Guss, Jan‐Ingmar Flock, Birgitta Henriques‐Normark, (unknown), (unknown), Romain Paillot, Andrew S. Waller	0
3	Sow vaccination with a novel recombinant protein vaccine protects piglets against Streptococcus suis infection 2025 ·Vaccine ·Sara Frosth, (unknown), Francesco Righetti, Joakim Bjerketorp, Karin Jacobsson, Birgitta Henriques‐Normark, Magdalena Jacobson, Bengt Guss, (unknown), Lars Frykberg, Jan‐Ingmar Flock, Andrew S. Waller	0
4	Digital dermatitis in Swedish dairy herds assessed by ELISA targeting Treponema phagedenis in bulk tank milk 2024 ·BMC Veterinary Research ·(unknown), Jenny Frössling, Anna Rosander, Joakim Bjerketorp, Reza Arabi Belaghi, Ingrid Hansson, Sara Frosth	3
5	Repurposing zidovudine and 5-fluoro-2′-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity–reducing agent uridine 2024 ·Journal of Antimicrobial Chemotherapy ·Jolanta J. Levenfors, Joakim Bjerketorp, Bengt Guss, (unknown), Sha Cao, Diarmaid Hughes, Anders Broberg, Bo Öberg	0
6	In-peptide amino acid racemization via inter-residue oxazoline intermediates during acidic hydrolysis 2021 ·Amino Acids ·Anders Broberg, (unknown), Jolanta J. Levenfors, Joakim Bjerketorp, Bengt Guss, Bo Öberg	11
7	Selective Isolation of Multidrug-Resistant Pedobacter spp., Producers of Novel Antibacterial Peptides 2021 ·Frontiers in Microbiology ·Joakim Bjerketorp, Jolanta J. Levenfors, (unknown), Bengt Guss, Bo Öberg, Anders Broberg	17
8	Antibacterial pyrrolidinyl and piperidinyl substituted 2,4-diacetylphloroglucinols from Pseudomonas protegens UP46 2020 ·The Journal of Antibiotics ·Jolanta J. Levenfors, (unknown), Joakim Bjerketorp, Jerry Ståhlberg, Rolf Larsson, Bengt Guss, Bo Öberg, Anders Broberg	4
9	Isolation of antibiotic-resistant bacteria in biogas digestate and their susceptibility to antibiotics 2020 ·Environmental Pollution ·He Sun, Joakim Bjerketorp, Jolanta J. Levenfors, Anna Schnürer	18
10	Antibacterial Isoquinoline Alkaloids from the Fungus Penicillium Spathulatum Em19 2019 ·Molecules ·(unknown), Jolanta J. Levenfors, Joakim Bjerketorp, Christer Sahlberg, Bengt Guss, Bo Öberg, Anders Broberg	25
11	Formulation and stabilization of an Arthrobacter strain with good storage stability and 4-chlorophenol-degradation activity for bioremediation 2018 ·Applied Microbiology and Biotechnology ·Joakim Bjerketorp, Wilfred F. M. Röling, Xinmei Feng, A Hernández, Hermann J. Heipieper, Sebastian Håkansson	23
12	Labradorins with Antibacterial Activity Produced by Pseudomonas sp. 2017 ·Molecules ·Anders Broberg, Joakim Bjerketorp, (unknown), Christer Sahlberg, Jolanta J. Levenfors	8
13	Effects of di- and polysaccharide formulations and storage conditions on survival of freeze-dried Sphingobium sp. 2013 ·World Journal of Microbiology and Biotechnology ·(unknown), Leticia Pizzul, Joakim Bjerketorp, Denny Mahlin, Sebastian Håkansson, Per Wessman	11
14	Soft inertial microfluidics for high throughput separation of bacteria from human blood cells 2009 ·Lab on a Chip ·Zhigang Wu, Benjamin P. Willing, Joakim Bjerketorp, Janet Jansson, Klas Hjort	202
15	Rapid lab-on-a-chip profiling of human gut bacteria 2007 ·Journal of Microbiological Methods ·Joakim Bjerketorp, (unknown), (unknown), Magnus Rosenquist, Wen‐Tso Liu, Janet Jansson	12
16	The von Willebrand factor-binding protein (vWbp) of Staphylococcus aureus is a coagulase 2004 ·FEMS Microbiology Letters ·Joakim Bjerketorp	72
17	A fibrinogen-binding protein ofStaphylococcus lugdunensis 2004 ·FEMS Microbiology Letters ·Martin Nilsson, Joakim Bjerketorp, Bengt Guss, Lars Frykberg	36
18	Sorting a Staphylococcus aureus phage display library against ex vivo biomaterial 2004 ·Journal of Medical Microbiology ·Joakim Bjerketorp, Anna Rosander, Martin Nilsson, Karin Jacobsson, Lars Frykberg	9
19	Shotgun phage display — Selection for bacterial receptins or other exported proteins 2003 ·Biological Procedures Online ·Karin Jacobsson, Anna Rosander, Joakim Bjerketorp, Lars Frykberg	42
20	Phage display as a novel screening method to identify extracellular proteins 2002 ·Journal of Microbiological Methods ·Anna Rosander, Joakim Bjerketorp, Lars Frykberg, Karin Jacobsson	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact